| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 14 | 2021 | 69 | 6.970 |
Why?
|
| Colitis | 18 | 2011 | 64 | 3.600 |
Why?
|
| Colon | 15 | 2017 | 98 | 3.030 |
Why?
|
| Stress, Psychological | 7 | 2020 | 541 | 2.550 |
Why?
|
| Inflammatory Bowel Diseases | 7 | 2017 | 85 | 2.090 |
Why?
|
| Macrophages | 5 | 2020 | 431 | 1.940 |
Why?
|
| Rats, Sprague-Dawley | 30 | 2020 | 1534 | 1.900 |
Why?
|
| Receptors, Calcitriol | 4 | 2020 | 59 | 1.850 |
Why?
|
| Disease Models, Animal | 22 | 2020 | 1300 | 1.540 |
Why?
|
| Intestinal Mucosa | 8 | 2017 | 115 | 1.540 |
Why?
|
| Rats | 34 | 2020 | 3261 | 1.510 |
Why?
|
| Pyrroles | 2 | 2020 | 54 | 1.380 |
Why?
|
| Pyrimidines | 2 | 2020 | 112 | 1.320 |
Why?
|
| Probiotics | 4 | 2017 | 25 | 1.240 |
Why?
|
| Inflammation | 4 | 2021 | 577 | 1.230 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 4 | 2022 | 25 | 1.220 |
Why?
|
| Animals | 43 | 2022 | 14307 | 1.150 |
Why?
|
| Vitamin D | 2 | 2020 | 176 | 1.130 |
Why?
|
| Physiology | 2 | 2018 | 14 | 1.110 |
Why?
|
| Trinitrobenzenesulfonic Acid | 14 | 2017 | 20 | 1.070 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 413 | 1.040 |
Why?
|
| Students | 3 | 2023 | 452 | 1.020 |
Why?
|
| Colonic Neoplasms | 3 | 2011 | 181 | 0.960 |
Why?
|
| Pituitary-Adrenal System | 3 | 2020 | 36 | 0.940 |
Why?
|
| Uterus | 3 | 2020 | 54 | 0.910 |
Why?
|
| Faculty | 1 | 2023 | 82 | 0.910 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2020 | 31 | 0.890 |
Why?
|
| Inflammation Mediators | 5 | 2020 | 120 | 0.860 |
Why?
|
| Disease Progression | 5 | 2018 | 580 | 0.840 |
Why?
|
| Receptors, Neurokinin-1 | 4 | 2017 | 23 | 0.820 |
Why?
|
| Colitis, Ulcerative | 2 | 2016 | 49 | 0.780 |
Why?
|
| Crohn Disease | 2 | 2016 | 55 | 0.770 |
Why?
|
| Female | 25 | 2022 | 19873 | 0.760 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2020 | 49 | 0.750 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2020 | 11 | 0.740 |
Why?
|
| Adrenal Glands | 1 | 2020 | 17 | 0.740 |
Why?
|
| Gastrointestinal Motility | 3 | 2014 | 18 | 0.730 |
Why?
|
| Biomedical Research | 2 | 2015 | 371 | 0.730 |
Why?
|
| Receptors, Opioid, mu | 2 | 2017 | 47 | 0.700 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 859 | 0.700 |
Why?
|
| Thinking | 1 | 2018 | 35 | 0.660 |
Why?
|
| Professional Role | 1 | 2018 | 38 | 0.660 |
Why?
|
| Endometrium | 2 | 2020 | 57 | 0.650 |
Why?
|
| Teaching | 1 | 2018 | 51 | 0.650 |
Why?
|
| Behavior, Animal | 2 | 2017 | 304 | 0.650 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2017 | 6 | 0.640 |
Why?
|
| Housing, Animal | 1 | 2017 | 11 | 0.640 |
Why?
|
| Receptor, trkA | 1 | 2017 | 7 | 0.640 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 104 | 0.640 |
Why?
|
| Nerve Growth Factor | 1 | 2017 | 25 | 0.630 |
Why?
|
| Neurogenesis | 1 | 2017 | 55 | 0.610 |
Why?
|
| Pain Threshold | 1 | 2017 | 24 | 0.600 |
Why?
|
| Quality of Life | 1 | 2021 | 459 | 0.600 |
Why?
|
| Receptors, Tachykinin | 2 | 2007 | 2 | 0.600 |
Why?
|
| Career Choice | 2 | 2018 | 44 | 0.600 |
Why?
|
| Environment | 1 | 2017 | 130 | 0.580 |
Why?
|
| Stress, Physiological | 1 | 2017 | 137 | 0.580 |
Why?
|
| Periaqueductal Gray | 1 | 2016 | 9 | 0.570 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 12 | 0.550 |
Why?
|
| Tissue Fixation | 1 | 2015 | 18 | 0.550 |
Why?
|
| Formaldehyde | 1 | 2015 | 33 | 0.550 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 131 | 0.530 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 185 | 0.530 |
Why?
|
| Male | 30 | 2022 | 18870 | 0.530 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 94 | 0.520 |
Why?
|
| Uterine Contraction | 1 | 2014 | 6 | 0.510 |
Why?
|
| Substance P | 3 | 2017 | 25 | 0.510 |
Why?
|
| Educational Measurement | 1 | 2015 | 80 | 0.500 |
Why?
|
| Medical Oncology | 1 | 2014 | 26 | 0.490 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 282 | 0.480 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2022 | 47 | 0.470 |
Why?
|
| Quinuclidines | 2 | 2010 | 5 | 0.470 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 600 | 0.460 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2005 | 325 | 0.450 |
Why?
|
| Documentation | 1 | 2012 | 15 | 0.450 |
Why?
|
| Piperidines | 2 | 2010 | 76 | 0.450 |
Why?
|
| Education, Medical | 1 | 2014 | 97 | 0.440 |
Why?
|
| Education, Graduate | 1 | 2012 | 27 | 0.440 |
Why?
|
| Career Mobility | 1 | 2012 | 24 | 0.440 |
Why?
|
| Lactobacillus | 2 | 2011 | 15 | 0.420 |
Why?
|
| Puerto Rico | 5 | 2016 | 1352 | 0.410 |
Why?
|
| Quinazolines | 1 | 2011 | 31 | 0.410 |
Why?
|
| Humans | 17 | 2023 | 34853 | 0.400 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 117 | 0.400 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 81 | 0.390 |
Why?
|
| Chronic Disease | 6 | 2017 | 469 | 0.370 |
Why?
|
| Acute Disease | 6 | 2017 | 141 | 0.360 |
Why?
|
| Corticosterone | 4 | 2017 | 73 | 0.320 |
Why?
|
| Endometritis | 1 | 2007 | 2 | 0.320 |
Why?
|
| Valine | 1 | 2007 | 31 | 0.320 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 756 | 0.310 |
Why?
|
| Communication | 2 | 2023 | 170 | 0.310 |
Why?
|
| Tetrazoles | 1 | 2007 | 49 | 0.310 |
Why?
|
| Colony Count, Microbial | 2 | 2007 | 66 | 0.310 |
Why?
|
| Gastric Mucosa | 2 | 2005 | 50 | 0.280 |
Why?
|
| Acetylcholine | 1 | 2006 | 68 | 0.280 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2005 | 3 | 0.270 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 32 | 0.270 |
Why?
|
| Biopsy | 2 | 2016 | 151 | 0.260 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 284 | 0.250 |
Why?
|
| Platelet Activating Factor | 2 | 1995 | 8 | 0.250 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 137 | 0.250 |
Why?
|
| Neoplasms | 1 | 2014 | 1033 | 0.240 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2007 | 112 | 0.240 |
Why?
|
| Time Factors | 5 | 2014 | 1681 | 0.240 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 53 | 0.230 |
Why?
|
| Phosphorylation | 2 | 2017 | 878 | 0.230 |
Why?
|
| Hippocampus | 2 | 2019 | 546 | 0.220 |
Why?
|
| Anxiety | 3 | 2022 | 705 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 968 | 0.220 |
Why?
|
| Blood Vessels | 1 | 2002 | 32 | 0.220 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1056 | 0.220 |
Why?
|
| Metagenome | 2 | 2011 | 28 | 0.200 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 153 | 0.200 |
Why?
|
| RNA, Messenger | 4 | 2020 | 1152 | 0.200 |
Why?
|
| Metabolomics | 1 | 2021 | 76 | 0.190 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 520 | 0.190 |
Why?
|
| Middle Aged | 5 | 2016 | 9642 | 0.190 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 11 | 0.180 |
Why?
|
| Stomach Diseases | 2 | 1997 | 5 | 0.180 |
Why?
|
| Bacteria | 1 | 2003 | 245 | 0.180 |
Why?
|
| Cytokines | 2 | 2017 | 569 | 0.180 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 51 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2011 | 157 | 0.180 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 396 | 0.170 |
Why?
|
| Haptens | 2 | 1995 | 19 | 0.170 |
Why?
|
| Job Description | 1 | 2018 | 6 | 0.170 |
Why?
|
| Peroxidase | 3 | 2007 | 50 | 0.170 |
Why?
|
| Models, Educational | 1 | 2018 | 41 | 0.170 |
Why?
|
| Aged | 4 | 2016 | 6448 | 0.160 |
Why?
|
| Urocortins | 1 | 2017 | 4 | 0.160 |
Why?
|
| Receptors, Growth Factor | 1 | 2017 | 13 | 0.160 |
Why?
|
| Astrocytes | 1 | 2019 | 203 | 0.160 |
Why?
|
| Adult | 4 | 2016 | 11034 | 0.160 |
Why?
|
| Recurrence | 3 | 2005 | 125 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2020 | 490 | 0.150 |
Why?
|
| Enkephalins | 1 | 2017 | 31 | 0.150 |
Why?
|
| Receptors, Neurokinin-2 | 2 | 2007 | 2 | 0.150 |
Why?
|
| Program Evaluation | 1 | 2018 | 316 | 0.150 |
Why?
|
| Feces | 1 | 2017 | 110 | 0.150 |
Why?
|
| Prevalence | 2 | 2016 | 1425 | 0.150 |
Why?
|
| Spinal Cord | 1 | 2017 | 85 | 0.150 |
Why?
|
| Enkephalin, Methionine | 1 | 2016 | 7 | 0.140 |
Why?
|
| Enkephalin, Leucine | 1 | 2016 | 5 | 0.140 |
Why?
|
| Oligopeptides | 1 | 2017 | 97 | 0.140 |
Why?
|
| Curriculum | 1 | 2018 | 237 | 0.140 |
Why?
|
| beta-Endorphin | 1 | 2016 | 14 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2017 | 161 | 0.140 |
Why?
|
| Cell Lineage | 1 | 2016 | 88 | 0.140 |
Why?
|
| Leukocytes | 1 | 1996 | 68 | 0.140 |
Why?
|
| Young Adult | 2 | 2016 | 4012 | 0.130 |
Why?
|
| Staining and Labeling | 1 | 2015 | 100 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 338 | 0.130 |
Why?
|
| School Admission Criteria | 1 | 2015 | 9 | 0.130 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 140 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 26 | 0.130 |
Why?
|
| Homeostasis | 1 | 2016 | 172 | 0.130 |
Why?
|
| Defecation | 1 | 2014 | 5 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 255 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 92 | 0.130 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1349 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 26 | 0.130 |
Why?
|
| Demography | 1 | 2015 | 167 | 0.120 |
Why?
|
| Leukocyte Count | 2 | 2012 | 74 | 0.120 |
Why?
|
| Maze Learning | 1 | 2014 | 100 | 0.120 |
Why?
|
| Phenotype | 1 | 2016 | 650 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2016 | 562 | 0.110 |
Why?
|
| Job Application | 1 | 2012 | 3 | 0.110 |
Why?
|
| Indomethacin | 2 | 2007 | 24 | 0.110 |
Why?
|
| Organizational Objectives | 1 | 2012 | 30 | 0.110 |
Why?
|
| Professional Competence | 1 | 2012 | 34 | 0.110 |
Why?
|
| Staff Development | 1 | 2012 | 28 | 0.110 |
Why?
|
| Writing | 1 | 2012 | 33 | 0.110 |
Why?
|
| Ascitic Fluid | 1 | 2012 | 7 | 0.110 |
Why?
|
| Neurons | 1 | 2019 | 1130 | 0.110 |
Why?
|
| Swimming | 1 | 2012 | 37 | 0.110 |
Why?
|
| Rabbits | 3 | 2002 | 278 | 0.110 |
Why?
|
| Angiostatins | 1 | 2011 | 2 | 0.110 |
Why?
|
| Endostatins | 1 | 2011 | 5 | 0.100 |
Why?
|
| Bifidobacterium | 1 | 2011 | 3 | 0.100 |
Why?
|
| Streptococcus | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mast Cells | 1 | 2012 | 77 | 0.100 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 48 | 0.100 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 358 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 122 | 0.100 |
Why?
|
| Child | 1 | 2018 | 2875 | 0.100 |
Why?
|
| Rats, Wistar | 5 | 2001 | 202 | 0.100 |
Why?
|
| Calcium | 1 | 1992 | 445 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 166 | 0.090 |
Why?
|
| E-Selectin | 2 | 2005 | 19 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2005 | 53 | 0.080 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 2007 | 1 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 834 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2007 | 9 | 0.080 |
Why?
|
| Cell Line | 1 | 2011 | 1289 | 0.080 |
Why?
|
| Neurokinin A | 1 | 2007 | 1 | 0.080 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 2007 | 1 | 0.080 |
Why?
|
| Exons | 1 | 2007 | 80 | 0.080 |
Why?
|
| Glucocorticoids | 2 | 1999 | 80 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2007 | 63 | 0.080 |
Why?
|
| Tetrodotoxin | 1 | 2007 | 20 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2016 | 1802 | 0.080 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 21 | 0.080 |
Why?
|
| Stomach | 2 | 1999 | 43 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2007 | 57 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2007 | 162 | 0.070 |
Why?
|
| Carcinoma | 1 | 2007 | 94 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 68 | 0.070 |
Why?
|
| Naproxen | 2 | 1997 | 6 | 0.070 |
Why?
|
| Benzamides | 1 | 2007 | 76 | 0.070 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 32 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1149 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 51 | 0.070 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2005 | 4 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2005 | 24 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 4 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2005 | 21 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 12 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 200 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 298 | 0.070 |
Why?
|
| Hormone Antagonists | 2 | 2022 | 15 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 605 | 0.060 |
Why?
|
| Mice | 1 | 2015 | 5668 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 555 | 0.060 |
Why?
|
| United States | 1 | 2014 | 3894 | 0.060 |
Why?
|
| Probability | 1 | 2004 | 75 | 0.060 |
Why?
|
| Age of Onset | 1 | 2004 | 98 | 0.060 |
Why?
|
| Age Distribution | 1 | 2004 | 223 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2004 | 212 | 0.060 |
Why?
|
| Dextran Sulfate | 1 | 2003 | 14 | 0.060 |
Why?
|
| Mutation | 1 | 2007 | 1023 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 57 | 0.060 |
Why?
|
| Thromboxane B2 | 1 | 2002 | 8 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2002 | 66 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2002 | 57 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 131 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 639 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 528 | 0.050 |
Why?
|
| Microspheres | 2 | 1999 | 45 | 0.050 |
Why?
|
| Bacterial Translocation | 1 | 2001 | 1 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 608 | 0.050 |
Why?
|
| Prognosis | 1 | 2004 | 707 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2004 | 727 | 0.050 |
Why?
|
| Indazoles | 1 | 2020 | 9 | 0.050 |
Why?
|
| Pyridones | 1 | 2020 | 40 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2004 | 1422 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2004 | 1353 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 66 | 0.040 |
Why?
|
| Ethanol | 2 | 2001 | 188 | 0.040 |
Why?
|
| Tin | 1 | 1999 | 1 | 0.040 |
Why?
|
| Scandium | 1 | 1999 | 2 | 0.040 |
Why?
|
| Radioisotopes | 1 | 1999 | 15 | 0.040 |
Why?
|
| Liver Diseases | 1 | 1999 | 31 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 281 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 1999 | 69 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 2333 | 0.040 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1997 | 2 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 1997 | 9 | 0.040 |
Why?
|
| Cholestasis | 1 | 1997 | 9 | 0.040 |
Why?
|
| Analgesics | 1 | 1997 | 56 | 0.040 |
Why?
|
| Stomach Ulcer | 1 | 1996 | 5 | 0.040 |
Why?
|
| Liver | 1 | 1999 | 447 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1996 | 26 | 0.030 |
Why?
|
| Dinitrochlorobenzene | 1 | 1995 | 1 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 1995 | 8 | 0.030 |
Why?
|
| Chymases | 1 | 1995 | 3 | 0.030 |
Why?
|
| Animal Feed | 1 | 1996 | 42 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1442 | 0.030 |
Why?
|
| Glyceryl Ethers | 1 | 1995 | 1 | 0.030 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 1995 | 4 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 664 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 23 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1995 | 37 | 0.030 |
Why?
|
| Azepines | 1 | 1995 | 17 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1995 | 36 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1996 | 209 | 0.030 |
Why?
|
| Triazoles | 1 | 1995 | 85 | 0.030 |
Why?
|
| Adolescent | 1 | 2004 | 5035 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 406 | 0.030 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 1992 | 3 | 0.030 |
Why?
|
| Cell Movement | 1 | 1996 | 545 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Peritoneum | 1 | 2005 | 8 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 19 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 31 | 0.020 |
Why?
|
| Solubility | 1 | 2005 | 115 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2005 | 420 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2001 | 2 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2001 | 13 | 0.010 |
Why?
|
| Bacteria, Aerobic | 1 | 2001 | 7 | 0.010 |
Why?
|
| Mucus | 1 | 2001 | 13 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 2001 | 132 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 67 | 0.010 |
Why?
|
| Enterotoxins | 1 | 2001 | 32 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 91 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 44 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 103 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 296 | 0.010 |
Why?
|
| Fluorescein | 1 | 1999 | 15 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1999 | 21 | 0.010 |
Why?
|
| Dextrans | 1 | 1999 | 17 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1999 | 16 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1999 | 30 | 0.010 |
Why?
|
| Carbon Tetrachloride | 1 | 1999 | 5 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1999 | 32 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1999 | 24 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 71 | 0.010 |
Why?
|
| Mifepristone | 1 | 1999 | 33 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1999 | 322 | 0.010 |
Why?
|
| Immune Sera | 1 | 1997 | 59 | 0.010 |
Why?
|
| Ileal Diseases | 1 | 1997 | 2 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1997 | 6 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1997 | 22 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1997 | 23 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1999 | 613 | 0.010 |
Why?
|
| Neutrophils | 1 | 1995 | 124 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 1268 | 0.010 |
Why?
|